ZincOx Resources sells Jabal Salab joint venture

ZincOx Resources said Monday it is selling its Yemen arm to Ansan Wikfs, its joint venture partner in Jabal Salab.

ZincOx Resources said Monday it is selling its Yemen arm to Ansan Wikfs, its joint venture partner in Jabal Salab.

The disposal of ZincOx Resources (Yemen) Limited, which holds a 52% interest in Jabal Salab, will give Ansan Wikfs complete control of the venture.

Jabal Salab has the right to exploit the Jabali deposit in Yemen, which contains both silver and zinc.

The consideration for the sale includes series of deferred payments to be made from cash generated from the currently undeveloped Jabali deposit once mining operations commence.

The deferred payments are completely dependent on financing of the project and sale of products.

They are further dependent on the London Metal Exchange zinc and silver prices at the time of future sales of the products and are designed to recover the company's past investments in Jabal Salab.

Ansan Wikfs will make a nominal payment of $1.0 at the time of the transfer of ownership, acknowledging that the value will be in the project once developed.

"Due to the realignment of our corporate strategy towards recycling, our interest in primary natural resources has diminished and it is right therefore that our joint venture partner takes over the management and development of this exciting project," ZincOx Chairman, Andrew Woollett, said.

"With their very strong connections in the Middle East generally and Yemen in particular we believe they are best placed to pursue the financing of the project."

Shares fell 0.98% to 25.25p at 10:08 Monday.

RD

Recommended

Imperial Brands has an 8.3% yield – but what’s the catch?
Share tips

Imperial Brands has an 8.3% yield – but what’s the catch?

Tobacco company Imperial Brands boasts an impressive dividend yield, and the shares look cheap. But investors should beware, says Rupert Hargreaves. H…
20 May 2022
Investing in drugmakers: uncommon profits from curing rare diseases
Share tips

Investing in drugmakers: uncommon profits from curing rare diseases

Treatments for medical conditions with only a small number of sufferers can still be very attractive for pharmaceutical companies and investors becaus…
20 May 2022
Share tips of the week – 20 May
Share tips

Share tips of the week – 20 May

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
20 May 2022
Delivering profits: should you buy Royal Mail shares?
Share tips

Delivering profits: should you buy Royal Mail shares?

The volume of parcels delivered by Royal Mail soared during the pandemic, and so did its profits. But it has been coming under pressure lately. So, as…
19 May 2022

Most Popular

The ten highest dividend yields in the FTSE 100
Income investing

The ten highest dividend yields in the FTSE 100

Rupert Hargreaves looks at the FTSE 100’s top yielding stocks for income investors to consider.
18 May 2022
Aviva: a share for income investors to tuck away
Share tips

Aviva: a share for income investors to tuck away

Insurance giant Aviva is one of the highest yielding stocks in the FTSE 100 – and it’s cheap, too, making it a tempting target for income investors. R…
18 May 2022
Inflation is now at its highest since 1982 – is this the peak?
Inflation

Inflation is now at its highest since 1982 – is this the peak?

At 9%, UK inflation is at its highest for 40 years – and it’s not going anywhere soon, says John Stepek. That means you need to be much more active a…
18 May 2022